Trend Press Wire

Liver Cancer Diagnostic Market Projected to Cross $15.2 Billion by 2026

Press release   •   Aug 30, 2019 02:50 EDT

The global Liver Cancer Diagnostic Market size is estimated to reach at US$ 15.2 billion by 2026, registering a CAGR of 8.3% from 2018 to 2026, according to a new study by Acumen Research and Consulting.

Market Overview:

Liver Cancer Diagnostic Market 2018 - 2026 research report includes the SWOT analysis that's Strengths, Weakness, Opportunities and Threats which provides you complete analysis of competitors, market growth, market share and in addition as CAGR comparison by region. The report provides analysis of the global Liver Cancer Diagnostic Market for the period from 2016 to 2026, wherein 2018–2026 is the forecast period and 2018 is the base year. Data for 2017 has been included as historical information.

The report covers all trends and technologies expected to play a major role in growth of the global Liver Cancer Diagnostic Market during the forecast period. It highlights drivers, restraints, and opportunities expected to influence the market from 2018 to 2026. The study provides a holistic perspective on the Liver Cancer Diagnostic Market, in terms of revenue (in US$ Mn) and volume (in million units), across different regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America. The report highlights key trends affecting the Liver Cancer Diagnostic Market at the global level. Prominent countries/sub-regions covered in the report include the U.S., Canada, Germany, France, the U.K., Italy, Russia, India, China, Japan, South Korea, South East Asia, GCC, South Africa, and Brazil.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1039

The report comprises detailed ecosystem analysis, which provides a comprehensive view of the global Liver Cancer Diagnostic Market. Porter’s five forces model has also been included to help understand the competition landscape of the market. Additionally, current indicators of diverse macro-economic factors are contextualized under key market indicators.

The report also analyzes the Liver Cancer Diagnostic Market on the basis of various segments. A unique section in the report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred.

Scope of the Liver Cancer Diagnostic Market Report:

The study provides a decisive view of the Liver Cancer Diagnostic Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Market Segmentation:

Market By Screening Type

  • Laboratory Tests
    • Biomarkers
      • Oncofetal and Glycoprotein Antigens
      • Enzymes and Isoenzymes
      • Growth Factors and Receptors
      • Molecular Markers
      • Pathological Biomarkers
    • Blood Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America drove the worldwide market in 2018 representing over 34.7% piece of the overall industry. The region is relied upon to keep up the main position all through the forecast period upheld by excellent healthcare coverage inclusion and innovative progressions. U.S. initiates the market in North America region. Presence of a substantial base of target populace, demand for consideration diagnostics, enhanced innovation, and snappy reception of novel therapeutics and indicative methodologies are the key variables in responsible for the region’s large share.

Asia Pacific is relied upon to display the most astounding development because of expanding occurrences of liver cancer growth and developing significance of bringing down the expense of disease medicines in creating nations, for example, India and China. Developing restorative the travel industry in these nations is likewise expected to support the demand for demonstrative methodology for liver carcinoma. Furthermore, expanded demands in research and advancement and ideal government approaches for human services gadgets makers are foreseen to drive the locale's development further.

Market Participants / Key Players:

Few of the main player present in the global liver cancer diagnostic market are Thermo Fisher Scientific, Illumina, Inc.; Siemens Healthcare GmbH; Qiagen; and F. Hoffmann-La Roche Ltd.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

What is the overall structure of the market?

What was the historical value and what is the forecasted value of the market?

What are the key product level trends in the market?

What are the market level trends in the market?

Which of the market players are leading and what are their key differential strategies to retain their stronghold?

Which are the most lucrative regions in the market space?

Research Methodology

Secondary research sources that are typically referred to include, but are not limited to company websites, annual reports, financial reports, broker reports, investor presentations, SEC filings, internal and external proprietary databases, relevant patent and regulatory databases, national government documents, statistical databases, market reports, news articles, press releases, webcasts specific to companies operating in the market, national government documents, statistical databases, and Factiva.

Primary research involves e-mail interactions, telephonic interviews, and face-to-face interviews conducted for each market segment across geographies. ARC conducts primary interviews on an ongoing basis with market participants and commentators in order to validate the data and analysis. Primary interviews provide firsthand information on market size, market trends, growth trends, competition landscape, and market outlook. These help validate and strengthen secondary research findings. They also help develop the analysis team’s expertise and market understanding.

VIEW FULL RESEARCH REPORT@ https://www.acumenresearchandconsulting.com/liver-cancer-diagnostic-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Liver Cancer Diagnostic
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Liver Cancer Diagnostic Market By Screening Type
1.2.2.1. Global Liver Cancer Diagnostic Market Revenue and Growth Rate Comparison By Screening Type (2015-2026)
1.2.2.2. Global Liver Cancer Diagnostic Market Revenue Share By Screening Type in 2017
1.2.2.3. Laboratory Tests
1.2.2.4. Imaging
1.2.2.5. Endoscopy
1.2.2.6. Biopsy
1.2.2.7. Others
1.2.3. Liver Cancer Diagnostic Market by Geography
1.2.3.1. Global Liver Cancer Diagnostic Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Liver Cancer Diagnostic Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Liver Cancer Diagnostic Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Liver Cancer Diagnostic Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Liver Cancer Diagnostic Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Liver Cancer Diagnostic Major Manufacturers in 2017

CHAPTER 4. LIVER CANCER DIAGNOSTIC MARKET BY SCREENING TYPE

4.1. Global Liver Cancer Diagnostic Revenue By Screening Type
4.2. Laboratory Tests
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Imaging
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Endoscopy
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Biopsy
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Others
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. NORTH AMERICA LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

5.1. North America Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Liver Cancer Diagnostic Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

6.1. Europe Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

7.1. Asia-Pacific Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
7.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

8.1. Latin America Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

9.1. Middle East Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA LIVER CANCER DIAGNOSTIC MARKET BY COUNTRY

10.1. Africa Liver Cancer Diagnostic Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Liver Cancer Diagnostic Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Screening Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. Thermo Fisher Scientific
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Illumina, Inc.
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. Siemens Healthcare GmbH
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Qiagen
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. F. Hoffmann-La Roche Ltd.
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies
11.6. Others
11.6.1. Company Snapshot
11.6.2. Overview
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. Key Developments
11.6.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1039

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.